Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sushmita Bhattacharya is active.

Publication


Featured researches published by Sushmita Bhattacharya.


Biochimica et Biophysica Acta | 2009

Lipid induced overexpression of NF-κB in skeletal muscle cells is linked to insulin resistance

Pomy Barma; Sushmita Bhattacharya; Anirban Bhattacharya; Rakesh Kundu; Suman Dasgupta; Anindita Biswas; Shelley Bhattacharya; Sib Sankar Roy; Samir Bhattacharya

Lipid induced NF-kappaB activation is known to be associated with insulin resistance and type2 diabetes. Here we show that incubation of L6 skeletal muscle cells with palmitate significantly increased NF-kappaB p65 and NF-kappaB p50 expression along with their phosphorylation. NF-kappaB p65 siRNA inhibited palmitate induced overexpression of NF-kappaB p65 indicating palmitate effect on transcriptional activation. RT-PCR and real time PCR experiments also showed a significant increase in NF-kappaB p65 gene expression due to palmitate. Overexpression of NF-kappaB p65 by palmitate was linked to impairment of insulin activity. Palmitate effect on NF-kappaB gene and protein expression was found to be mediated by phospho-PKCepsilon as calphostin C (an inhibitor of PKC) and epsilonV1 (PKCepsilon translocation inhibitor) significantly reduced NF-kappaB expression. To understand the underlying mechanism, we purified NF-kappaB and pPKCepsilon from palmitate incubated skeletal muscle cells and their interaction in cell free system demonstrated the transfer of phosphate from PKCepsilon to NF-kappaB. This prompted us to transduct pPKCepsilon to the skeletal muscle cells. These cells showed increased amount of pNF-kappaB and NF-kappaB. Excess of NF-kappaB p65 pool thus created in the cells made them insulin resistant. Addition of NF-kappaB p65 siRNA and SN50 inhibited palmitate induced NF-kappaB p65 expression indicating NF-kappaB regulation of its gene expression. Increase of NF-kappaB did not affect the activation of IKK/IkappaB indicating NF-kappaB p65 expression to be a distinct effect of palmitate. Since NF-kappaB p65 is linked to several diseases, including type2 diabetes, this report may be important in understanding the pathogenicity of these diseases.


PLOS ONE | 2012

Vapor of Volatile Oils from Litsea cubeba Seed Induces Apoptosis and Causes Cell Cycle Arrest in Lung Cancer Cells

Soma Seal; Priyajit Chatterjee; Sushmita Bhattacharya; Durba Pal; Suman Dasgupta; Rakesh Kundu; Sandip Mukherjee; Shelley Bhattacharya; Mantu Bhuyan; Pranab R. Bhattacharyya; Gakul Baishya; Nabin C. Barua; Pranab Kumar Baruah; Paruchuri G. Rao; Samir Bhattacharya

Non-small cell lung carcinoma (NSCLC) is a major killer in cancer related human death. Its therapeutic intervention requires superior efficient molecule(s) as it often becomes resistant to present chemotherapy options. Here we report that vapor of volatile oil compounds obtained from Litsea cubeba seeds killed human NSCLC cells, A549, through the induction of apoptosis and cell cycle arrest. Vapor generated from the combined oils (VCO) deactivated Akt, a key player in cancer cell survival and proliferation. Interestingly VCO dephosphorylated Akt at both Ser473 and Thr308; through the suppression of mTOR and pPDK1 respectively. As a consequence of this, diminished phosphorylation of Bad occurred along with the decreased Bcl-xL expression. This subsequently enhanced Bax levels permitting the release of mitochondrial cytochrome c into the cytosol which concomitantly activated caspase 9 and caspase 3 resulting apoptotic cell death. Impairment of Akt activation by VCO also deactivated Mdm2 that effected overexpression of p53 which in turn upregulated p21 expression. This causes enhanced p21 binding to cyclin D1 that halted G1 to S phase progression. Taken together, VCO produces two prong effects on lung cancer cells, it induces apoptosis and blocked cancer cell proliferation, both occurred due to the deactivation of Akt. In addition, it has another crucial advantage: VCO could be directly delivered to lung cancer tissue through inhalation.


Fish Physiology and Biochemistry | 2007

Arsenic-induced responses in freshwater teleosts

Sushmita Bhattacharya; Anirban Bhattacharya; S. Roy

The environment is currently polluted by thousands of chemicals or xenobiotics introduced into the environment by man to meet the demands of the modern era. Every day we encounter this negative side of human civilization, but have done little to lessen the rate of pollution. Although the entire biosphere is polluted it is water resources that are the most polluted because water is the ultimate sink for many contaminants. Thus, fish are the most vulnerable of all animal species. They are helpless because they cannot avoid the polluted habitat and face this contamination by default. Nevertheless, fish are found to survive under extreme conditions when their natural habitat has been compromised to a great extent. However, fish are highly sensitive to small environmental changes and their populations gradually dwindle if pollution continues unabated. However, we know that there are instances when water is cleaned and the rate of repopulation by different fish species has gained momentum, restoring the ecological balance. Thus, fish are considered reliable bioindicators of water pollution and fish ecotoxicology has received much attention in recent years, and fish toxicology has been able to defend a significant position in the arena of xenobiotics research over the years. This review deals with some of the major intoxication and detoxication signals manifested by fish exposed to arsenic (As), which is presently one of the most worrying metalloids in water pollution.


Biochimica et Biophysica Acta | 2011

Mechanism of lipid induced insulin resistance: activated PKCε is a key regulator.

Suman Dasgupta; Sushmita Bhattacharya; Sudipta Maitra; Durba Pal; Subeer S. Majumdar; Asis Datta; Samir Bhattacharya

Fatty acids (FAs) are known to impair insulin signaling in target cells. Accumulating evidences suggest that one of the major sites of FAs adverse effect is insulin receptor (IR). However, the underlying mechanism is yet unclear. An important clue was indicated in leptin receptor deficient (db/db) diabetic mice where increased circulatory FAs was coincided with phosphorylated PKCε and reduced IR expression. We report here that central to this mechanism is the phosphorylation of PKCε by FAs. Kinase dead mutant of PKCε did not augment FA induced IRβ downregulation indicating phosphorylation of PKCε is crucial for FA induced IRβ reduction. Investigation with insulin target cells showed that kinase independent phosphorylation of PKCε by FA occurred through palmitoylation. Mutation at cysteine 276 and 474 residues in PKCε suppressed this process indicating participation of these two residues in palmitoylation. Phosphorylation of PKCε endowed it the ability to migrate to the nuclear region of insulin target cells. It was intriguing to search about how translocation of phosphorylated PKCε occurred without having canonical nuclear localization signal (NLS). We found that F-actin recognized phospho-form of PKCε and chaperoned it to the nuclear region where it interact with HMGA1 and Sp1, the transcription regulator of IR and HMGA1 gene respectively and impaired HMGA1 function. This resulted in the attenuation of HMGA1 driven IR transcription that compromised insulin signaling and sensitivity.


Molecular and Cellular Biochemistry | 2010

Insulin resistance due to lipid-induced signaling defects could be prevented by mahanine.

Anindita Biswas; Sushmita Bhattacharya; Suman Dasgupta; Rakesh Kundu; Sib Sankar Roy; Bikas C. Pal; Samir Bhattacharya

It is well known that free fatty acids (FFAs) play a key role in implementing insulin resistance and type 2 diabetes. Resources of chemical compounds that intervene the derogatory effect of FFAs are indeed very limited. We have isolated mahanine, a carbazole alkaloid, from the leaves of Murraya koenegii that prevented palmitate-induced inhibition of insulin-stimulated phosphorylation of IRβ, PI3K, PDK1, and Akt in L6 myotubes. This was also reflected in the palmitate-induced inhibition of insulin-stimulated [3H] 2-DOG uptake by L6 myotubes, where palmitate adverse effect was significantly blocked by mahanine. Previous reports indicated that one of the major targets of lipid-induced damage in insulin signaling pathway resulting impairment of insulin sensitivity is insulin receptor (IR). Here, we have observed that palmitate significantly increased pPKCε in both cytosol and nuclear region of L6 myotubes in comparison to control. Translocation of pPKCε to the nucleus was associated with the impairment of HMGA1, the architectural transcription factor of IR gene and all these were reversed by mahanine. Palmitate-induced activation of IKK/IκΒ/NF-κΒ pathway was also attenuated by mahanine. Taken together, mahanine showed encouraging possibility to deal with lipid induced insulin resistance. In order to examine it further, mahanine was administered on nutritionally induced type 2 diabetic golden hamsters; it significantly improved hyperglycemia in all the treated animals. Our results, therefore, suggest that mahanine acts on two important sites of lipid induced insulin resistance (i) impairment of IR gene expression and (ii) activation of NF-κΒ pathway, thus, showing promise for its therapeutic choice for type 2 diabetes.


Biochemical Pharmacology | 2011

Carlinoside reduces hepatic bilirubin accumulation by stimulating bilirubin-UGT activity through Nrf2 gene expression

Rakesh Kundu; Suman Dasgupta; Anindita Biswas; Sushmita Bhattacharya; Bikas C. Pal; Shelley Bhattacharya; Paruchuri G. Rao; Nabin C. Barua; Manobjyoti Bordoloi; Samir Bhattacharya

Accumulation of bilirubin, primarily because of its insolubility, has been found to be associated with liver diseases including jaundice. Free bilirubin is insoluble; its glucuronidation by bilirubin-UGT enzyme (UGT1A1) makes it soluble and eliminates it through urine and faeces. Taking CCl(4) induced rat liver dysfunction model, we demonstrated that suppression of UGT1A1 activity in rat liver increased serum bilirubin level which could be reversed by carlinoside (Cln), a flavone glycoside. Although Cln is a flavone compound, it escaped self-glucuronidation in the intestine and readily absorbed. Kinetic study of microsomal UGT1A1 from HepG2 cells suggested that Cln enhanced enzyme activity by increasing V(max) without altering K(m). This altered V(max) was found to be due to UGT1A1 overexpression by Cln which was observed in both HepG2 and rat primary hepatocytes. Since Nrf2 is the transcription factor of UGT1A1, we examined whether Cln effect on UGT1A1 overexpression is mediated through Nrf2. In Nrf2 knock-out cells, Cln could not elevate UGT1A1 activity indicating Nrf2 to be its target. Cln significantly increased Nrf2 gene expression in HepG2 cells which was subsequently localized in nuclear region. Results from ChIP assay showed that Cln markedly augmented Nrf2 binding to UGT1A1 promoter that consequently enhanced reporter activity. Our findings therefore show that Cln upregulated Nrf2 gene expression, increased its nuclear translocation and stimulated UGT1A1 promoter activity. Total outcome of these events brought about a significant increase of bilirubin glucuronidation. Cln therefore could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction.


PLOS ONE | 2017

A Small Insulinomimetic Molecule Also Improves Insulin Sensitivity in Diabetic Mice

Subeer S. Majumdar; Sandip Mukherjee; Mrittika Chattopadhyay; Sushmita Bhattacharya; Suman Dasgupta; Sahid Hussain; Saitanya K. Bharadwaj; Dhrubajyoti Talukdar; Abul Usmani; Bhola Shankar Pradhan; Pronobesh Chattopadhyay; Satinath Mukhopadhyay; Tushar K Maity; Samir Bhattacharya

Dramatic increase of diabetes over the globe is in tandem with the increase in insulin requirement. This is because destruction and dysfunction of pancreatic β-cells are of common occurrence in both Type1 diabetes and Type2 diabetes, and insulin injection becomes a compulsion. Because of several problems associated with insulin injection, orally active insulin mimetic compounds would be ideal substitute. Here we report a small molecule, a peroxyvanadate compound i.e. DmpzH[VO(O2)2(dmpz)], henceforth referred as dmp, which specifically binds to insulin receptor with considerable affinity (KD-1.17μM) thus activating insulin receptor tyrosine kinase and its downstream signaling molecules resulting increased uptake of [14C] 2 Deoxy-glucose. Oral administration of dmp to streptozotocin treated BALB/c mice lowers blood glucose level and markedly stimulates glucose and fatty acid uptake by skeletal muscle and adipose tissue respectively. In db/db mice, it greatly improves insulin sensitivity through excess expression of PPARγ and its target genes i.e. adiponectin, CD36 and aP2. Study on the underlying mechanism demonstrated that excess expression of Wnt3a decreased PPARγ whereas dmp suppression of Wnt3a gene increased PPARγ expression which subsequently augmented adiponectin. Increased production of adiponectin in db/db mice due to dmp effected lowering of circulatory TG and FFA levels, activates AMPK in skeletal muscle and this stimulates mitochondrial biogenesis and bioenergetics. Decrease of lipid load along with increased mitochondrial activity greatly improves energy homeostasis which has been found to be correlated with the increased insulin sensitivity. The results obtained with dmp, therefore, strongly indicate that dmp could be a potential candidate for insulin replacement therapy.


Biochemical Journal | 2010

NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance

Suman Dasgupta; Sushmita Bhattacharya; Anindita Biswas; Subeer S. Majumdar; Satinath Mukhopadhyay; Sukanta Ray; Samir Bhattacharya


Archive | 2012

INSULIN MIMETIC ACTIVE COMPRISING OXODIPEROXO VANADATES AND A PHARAMACEUTICAL COMPOSITION OBTAINED THEREOF

Chaudhuri, Mihir, K.; Sahid Hussain; Saitanya K. Bharadwaj; Upasana Bora Sinha; Dhrubajyoti Talukdar; Subeer S. Majumdar; Sushmita Bhattacharya; Suman Dasgupta; Rakesh Kundu; Samir Bhattacharya; Shelley Bhattacharya


Archive | 2012

A synergistic pharmaceutical composition useful for the treatment of lung cancer

Mantu Bhuyan; Pranab Ram Bhattacharyya; Pranab Kumar Baruah; Nabin C. Barua; Paruchuri Gangadhar Rao; Sushmita Bhattacharya; Rakesh Kundu; Priyajit Chatterjee; Soma Seal; Sandeep Mukherjee; Suman Dasgupta; Sudipta Moitra; Shelley Bhattacharya; Samir Bhattacharya

Collaboration


Dive into the Sushmita Bhattacharya's collaboration.

Top Co-Authors

Avatar

Samir Bhattacharya

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Suman Dasgupta

Visva-Bharati University

View shared research outputs
Top Co-Authors

Avatar

Rakesh Kundu

Visva-Bharati University

View shared research outputs
Top Co-Authors

Avatar

Nabin C. Barua

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paruchuri Gangadhar Rao

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Manobjyoti Bordoloi

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Pomy Barma

Indian Institute of Chemical Biology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bikas C. Pal

Indian Institute of Chemical Biology

View shared research outputs
Researchain Logo
Decentralizing Knowledge